Summary

The global L-Carnosine market was valued at US$ 21.88 million in 2025 and is anticipated to reach US$ 30.33 million by 2032, at a CAGR of 5.57% from 2026 to 2032.
The North American market for L-Carnosine is projected to increase from US$ 3.17 million in 2025 to US$ 4.13 million by 2032, at a CAGR of 4.70% over 2026–2032.
The Asia-Pacific market for L-Carnosine is projected to rise from US$ 13.02 million in 2025 to US$ 18.36 million by 2032, at a CAGR of 5.86% over 2026–2032.
The Europe market for L-Carnosine is projected to rise from US$ 4.82 million in 2025 to US$ 6.61 million by 2032, at a CAGR of 5.25% over 2026–2032.
Major global manufacturers of L-Carnosine include Fushilai Pharmaceutical, Hamari Chemicals, Symrise, Wuhan BJM Pharm, Hubei Huntide Biotech, Jiangsu Chengxin Pharmaceutical, Belle Chemical, Shanghai Xutai Biotechnology, and Hangzhou Weitai Biological, etc. In 2025, the world’s top three vendors accounted for approximately 78.65% of revenue.
This report delivers a comprehensive overview of the global L-Carnosine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding L-Carnosine. The L-Carnosine market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global L-Carnosine market comprehensively. Regional market sizes by Type, by Application, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist L-Carnosine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
 Fushilai Pharmaceutical
 Hamari Chemicals
 Symrise
 Wuhan BJM Pharm
 Hubei Huntide Biotech
 Jiangsu Chengxin Pharmaceutical
 Belle Chemical
 Shanghai Xutai Biotechnology
 Hangzhou Weitai Biological
 Jing Jing Pharmaceutical
 Suzhou Biosynthetica

Segment by Type
 Purity ≥99%
 Purity ≥98%

Segment by Application
Dietary Supplements
 Pharmaceutical
 Cosmetics and Personal Care

Consumption by Region
North America
 United States
 Canada

 Asia-Pacific
 China
 Japan
 South Korea
 India
 Australia
 Southeast Asia

 Europe
 Germany
 France
 U.K.
 Italy
 Spain
 Rest of Europe

 Latin America
 Mexico
 Brazil

 Middle East & Africa
 Middle East
 Africa

Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for L-Carnosine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines L-Carnosine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

ページTOPに戻る

Table of Contents

1 L-Carnosine Market Overview 1
1.1 Product Definition 1
1.2 L-Carnosine by Type 1
1.2.1 Global L-Carnosine Market Value Comparison by Type (2021-2032) 2
1.2.2 Purity ≥99% 3
1.2.3 Purity ≥98% 4
1.3 L-Carnosine by Application 4
1.3.1 Global L-Carnosine Market Value by Application (2021-2032) 4
1.3.2 Dietary Supplements 6
1.3.3 Pharmaceutical 7
1.3.4 Cosmetics and Personal Care 7
1.4 Global L-Carnosine Market Size Estimates and Forecasts 8
1.4.1 Global L-Carnosine Revenue 2021-2032 8
1.4.2 Global L-Carnosine Sales 2021-2032 9
1.4.3 Global L-Carnosine Market Average Price (2021-2032) 10
1.5 Assumptions and Limitations 10
2 L-Carnosine Market Competition by Manufacturers 13
2.1 Global L-Carnosine Sales Market Share by Manufacturers (2021-2026) 13
2.2 Global L-Carnosine Revenue Market Share by Manufacturers (2021-2026) 15
2.3 Global L-Carnosine Average Price by Manufacturers (2021-2026) 18
2.4 Global Key Players of L-Carnosine, Industry Ranking, 2024 vs 2025 18
2.5 Global Key Manufacturers of L-Carnosine, Manufacturing Footprints and Headquarters 19
2.6 Global Key Manufacturers of L-Carnosine, Product Types and Applications 20
2.7 Global Key Manufacturers of L-Carnosine Establish Date 21
2.8 Global L-Carnosine Market Competitive Situation and Trends 22
2.8.1 Global L-Carnosine Market Concentration Rate 22
2.8.2 The Top 3 and Top 5 Global L-Carnosine Players Market Share by Revenue 23
2.8.3 Global L-Carnosine Market Share by Company Tier (Tier 1, Tier 2, and Tier 3) 23
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans 25
3 Global L-Carnosine Market Scenario by Region 26
3.1 Global L-Carnosine Market Size by Region: 2021 vs 2025 vs 2032 26
3.2 Global L-Carnosine Sales by Region: 2021-2032 27
3.2.1 Global L-Carnosine Sales by Region: 2021-2026 27
3.2.2 Global L-Carnosine Sales by Region: 2027-2032 28
3.3 Global L-Carnosine Revenue by Region: 2021-2032 28
3.3.1 Global L-Carnosine Revenue by Region: 2021-2026 28
3.3.2 Global L-Carnosine Revenue by Region: 2027-2032 29
3.4 North America L-Carnosine Market Facts & Figures by Country 30
3.4.1 North America L-Carnosine Market Size by Country: 2021 vs 2025 vs 2032 30
3.4.2 North America L-Carnosine Sales by Country (2021-2032) 30
3.4.3 North America L-Carnosine Revenue by Country (2021-2032) 31
3.4.4 United States 32
3.4.5 Canada 33
3.5 Europe L-Carnosine Market Facts & Figures by Country 33
3.5.1 Europe L-Carnosine Market Size by Country: 2021 vs 2025 vs 2032 33
3.5.2 Europe L-Carnosine Sales by Country (2021-2032) 34
3.5.3 Europe L-Carnosine Revenue by Country (2021-2032) 35
3.5.4 Germany 36
3.5.5 France 37
3.5.6 U.K. 37
3.5.7 Italy 38
3.5.8 Spain 38
3.6 Asia Pacific L-Carnosine Market Facts & Figures by Region 39
3.6.1 Asia Pacific L-Carnosine Market Size by Region: 2021 vs 2025 vs 2032 39
3.6.2 Asia Pacific L-Carnosine Sales by Region (2021-2032) 39
3.6.3 Asia Pacific L-Carnosine Revenue by Region (2021-2032) 40
3.6.4 China 42
3.6.5 Japan 42
3.6.6 South Korea 43
3.6.7 India 43
3.6.8 Australia 44
3.6.9 Southeast Asia 44
3.7 Latin America L-Carnosine Market Facts & Figures by Country 45
3.7.1 Latin America L-Carnosine Market Size by Country: 2021 vs 2025 vs 2032 45
3.7.2 Latin America L-Carnosine Sales by Country (2021-2032) 45
3.7.3 Latin America L-Carnosine Revenue by Country 46
3.7.4 Mexico 47
3.7.5 Brazil 48
3.8 Middle East and Africa L-Carnosine Market Facts & Figures by Country 48
3.8.1 Middle East and Africa L-Carnosine Market Size by Country: 2021 vs 2025 vs 2032 48
3.8.2 Middle East and Africa L-Carnosine Sales by Country (2021-2032) 49
3.8.3 Middle East and Africa L-Carnosine Revenue by Country 50
3.8.4 Middle East 51
3.8.5 Africa 51
4 Segment by Type 52
4.1 Global L-Carnosine Sales by Type (2021-2032) 52
4.1.1 Global L-Carnosine Sales by Type (2021-2026) 52
4.1.2 Global L-Carnosine Sales by Type (2027-2032) 52
4.1.3 Global L-Carnosine Sales Market Share by Type (2021-2032) 52
4.2 Global L-Carnosine Revenue by Type (2021-2032) 53
4.2.1 Global L-Carnosine Revenue by Type (2021-2026) 53
4.2.2 Global L-Carnosine Revenue by Type (2027-2032) 53
4.2.3 Global L-Carnosine Revenue Market Share by Type (2021-2032) 54
4.3 Global L-Carnosine Price by Type (2021-2032) 55
5 Segment by Application 56
5.1 Global L-Carnosine Sales by Application (2021-2032) 56
5.1.1 Global L-Carnosine Sales by Application (2021-2026) 56
5.1.2 Global L-Carnosine Sales by Application (2027-2032) 56
5.1.3 Global L-Carnosine Sales Market Share by Application (2021-2032) 56
5.2 Global L-Carnosine Revenue by Application (2021-2032) 57
5.2.1 Global L-Carnosine Revenue by Application (2021-2026) 57
5.2.2 Global L-Carnosine Revenue by Application (2027-2032) 58
5.2.3 Global L-Carnosine Revenue Market Share by Application (2021-2032) 58
5.3 Global L-Carnosine Price by Application (2021-2032) 59
6 Key Companies Profiled 61
6.1 Fushilai Pharmaceutical 61
6.1.1 Fushilai Pharmaceutical Company Information 61
6.1.2 Fushilai Pharmaceutical Description and Business Overview 61
6.1.3 Fushilai Pharmaceutical L-Carnosine Sales, Revenue, and Gross Margin (2021-2026) 62
6.1.4 Fushilai Pharmaceutical L-Carnosine Product Portfolio 62
6.2 Hamari Chemicals 63
6.2.1 Hamari Chemicals Company Information 63
6.2.2 Hamari Chemicals Description and Business Overview 63
6.2.3 Hamari Chemicals L-Carnosine Sales, Revenue, and Gross Margin (2021-2026) 64
6.2.4 Hamari Chemicals L-Carnosine Product Portfolio 64
6.3 Symrise 66
6.3.1 Symrise Company Information 66
6.3.2 Symrise Description and Business Overview 66
6.3.3 Symrise L-Carnosine Sales, Revenue, and Gross Margin (2021-2026) 67
6.3.4 Symrise L-Carnosine Product Portfolio 67
6.4 Wuhan BJM Pharm 68
6.4.1 Wuhan BJM Pharm Company Information 68
6.4.2 Wuhan BJM Pharm Description and Business Overview 68
6.4.3 Wuhan BJM Pharm L-Carnosine Sales, Revenue, and Gross Margin (2021-2026) 69
6.4.4 Wuhan BJM Pharm L-Carnosine Product Portfolio 69
6.5 Hubei Huntide Biotech 69
6.5.1 Hubei Huntide Biotech Company Information 69
6.5.2 Hubei Huntide Biotech Description and Business Overview 70
6.5.3 Hubei Huntide Biotech L-Carnosine Sales, Revenue, and Gross Margin (2021-2026) 70
6.5.4 Hubei Huntide Biotech L-Carnosine Product Portfolio 71
6.6 Jiangsu Chengxin Pharmaceutical 71
6.6.1 Jiangsu Chengxin Pharmaceutical Company Information 71
6.6.2 Jiangsu Chengxin Pharmaceutical Description and Business Overview 72
6.6.3 Jiangsu Chengxin Pharmaceutical L-Carnosine Sales, Revenue, and Gross Margin (2021-2026) 72
6.6.4 Jiangsu Chengxin Pharmaceutical L-Carnosine Product Portfolio 72
6.7 Belle Chemical 73
6.7.1 Belle Chemical Company Information 73
6.7.2 Belle Chemical Description and Business Overview 74
6.7.3 Belle Chemical L-Carnosine Sales, Revenue, and Gross Margin (2021-2026) 74
6.7.4 Belle Chemical L-Carnosine Product Portfolio 74
6.8 Shanghai Xutai Biotechnology 75
6.8.1 Shanghai Xutai Biotechnology Company Information 75
6.8.2 Shanghai Xutai Biotechnology Description and Business Overview 76
6.8.3 Shanghai Xutai Biotechnology L-Carnosine Sales, Revenue, and Gross Margin (2021-2026) 76
6.8.4 Shanghai Xutai Biotechnology L-Carnosine Product Portfolio 77
6.9 Hangzhou Weitai Biological 77
6.9.1 Hangzhou Weitai Biological Company Information 77
6.9.2 Hangzhou Weitai Biological Description and Business Overview 78
6.9.3 Hangzhou Weitai Biological L-Carnosine Sales, Revenue, and Gross Margin (2021-2026) 78
6.9.4 Hangzhou Weitai Biological L-Carnosine Product Portfolio 78
6.10 Jing Jing Pharmaceutical 79
6.10.1 Jing Jing Pharmaceutical Company Information 79
6.10.2 Jing Jing Pharmaceutical Description and Business Overview 80
6.10.3 Jing Jing Pharmaceutical L-Carnosine Sales, Revenue, and Gross Margin (2021-2026) 80
6.10.4 Jing Jing Pharmaceutical L-Carnosine Product Portfolio 80
6.11 Suzhou Biosynthetica 81
6.11.1 Suzhou Biosynthetica Company Information 81
6.11.2 Suzhou Biosynthetica Description and Business Overview 82
6.11.3 Suzhou Biosynthetica L-Carnosine Sales, Revenue, and Gross Margin (2021-2026) 82
6.11.4 Suzhou Biosynthetica L-Carnosine Product Portfolio 82
7 Industry Chain and Sales Channels Analysis 84
7.1 L-Carnosine Industry Chain Analysis 84
7.2 L-Carnosine Raw Material Supply Analysis 84
7.2.1 Key Raw Materials 84
7.2.2 Key Suppliers of Raw Materials 85
7.3 L-Carnosine Production Mode & Process Analysis 85
7.4 L-Carnosine Sales and Marketing 86
7.5 L-Carnosine Customer Analysis 87
8 L-Carnosine Market Dynamics 88
8.1 L-Carnosine Industry Trends 88
8.2 L-Carnosine Market Drivers 88
8.3 L-Carnosine Market Restraints 89
9 Research Findings and Conclusion 90
10 Methodology and Data Source 91
10.1 Methodology/Research Approach 91
10.1.1 Research Programs/Design 91
10.1.2 Market Size Estimation 92
10.1.3 Market Breakdown and Data Triangulation 93
10.2 Data Source 94
10.2.1 Secondary Sources 94
10.2.2 Primary Sources 95
10.3 Author List 97
10.4 Disclaimer 97